These findings imply that even in atrophic DFSP, detection of the COL1A1-PDGFB fusion gene is a powerful tool for molecular diagnosis to differentiate other benign/malignant neoplasms. The gene discussed is COL1A1; the disease is dermatofibrosarcoma protuberans.